β¨ Medicines Consent Notices
25 OCTOBER
NEW ZEALAND GAZETTE
3641
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product: Colgate Total plus Whitening Fluoride Toothpaste
Active Ingredient(s): Sodium fluoride 0.22%w/w equivalent to 1000ppm fluoride ion
Triclosan 0.3%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer(s): Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7448
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Metalyse
Active Ingredient(s): Tenecteplase 30mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany
Product: Metalyse
Active Ingredient(s): Tenecteplase 40mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany
Product: Metalyse
Active Ingredient(s): Tenecteplase 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany
Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7449
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Stocrin
Active Ingredient(s): Efavirenz 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Stocrin
Active Ingredient(s): Efavirenz 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7450
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 145
Gazette.govt.nz —
NZ Gazette 2001, No 145
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Related Product
π₯ Health & Social Welfare16 October 2001
Medicines Act, New Related Product, Distribution Consent, Toothpaste, Colgate
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social Welfare16 October 2001
Medicines Act, Changed Medicines, Distribution Consent, Metalyse, Boehringer Ingelheim
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Provisional Consent to Distribution of New Medicine
π₯ Health & Social Welfare16 October 2001
Medicines Act, Provisional Consent, New Medicine, Stocrin, Merck Sharp & Dohme
- G. R. Boyd, Chief Advisor, Safety and Regulation